XIAMEN AMOYTOP BIOTECH CO.,LTD.
特宝生物
XIAMEN AMOYTOP BIOTECH CO.,LTD.
Biotech/Healthcare
Amoytop Biotech specializes in the R&D and commercialization of biopharmaceuticals based on genetic engineering technologies, providing products including biologics and injectable drugs. Its marketed products include Pegberon®, a national Class I novel biologic, and three products formerly…
Latest round: Post-IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.